2023 Q3 Form 10-Q Financial Statement

#000132638023000047 Filed on September 06, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2022 Q3
Revenue $1.164B $1.136B
YoY Change 2.45% -4.01%
Cost Of Revenue $857.9M $853.8M
YoY Change 0.48% -1.01%
Gross Profit $305.9M $282.2M
YoY Change 8.4% -12.06%
Gross Profit Margin 26.28% 24.84%
Selling, General & Admin $322.5M $387.5M
YoY Change -16.77% 2.27%
% of Gross Profit 105.43% 137.31%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $12.60M $15.30M
YoY Change -17.65% -13.07%
% of Gross Profit 4.12% 5.42%
Operating Expenses $322.5M $387.5M
YoY Change -16.77% 2.27%
Operating Profit -$16.60M -$107.8M
YoY Change -84.6% 85.86%
Interest Expense $11.60M $300.0K
YoY Change 3766.67% -50.0%
% of Operating Profit
Other Income/Expense, Net $2.000M $0.00
YoY Change
Pretax Income -$3.000M -$107.5M
YoY Change -97.21% 83.76%
Income Tax -$200.0K $1.200M
% Of Pretax Income
Net Earnings -$2.800M -$108.7M
YoY Change -97.42% 76.46%
Net Earnings / Revenue -0.24% -9.57%
Basic Earnings Per Share -$0.01 -$0.36
Diluted Earnings Per Share -$0.01 -$0.36
COMMON SHARES
Basic Shares Outstanding 304.8M shares 304.2M shares
Diluted Shares Outstanding 304.8M shares 304.2M shares

Balance Sheet

Concept 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.195B $908.9M
YoY Change 31.44% -47.17%
Cash & Equivalents $894.7M $908.9M
Short-Term Investments $300.0M
Other Short-Term Assets $58.00M $107.3M
YoY Change -45.95% -5.79%
Inventory $676.9M $734.8M
Prepaid Expenses $58.00M $275.9M
Receivables $75.60M $99.60M
Other Receivables $0.00 $168.6M
Total Short-Term Assets $2.005B $2.019B
YoY Change -0.69% -24.0%
LONG-TERM ASSETS
Property, Plant & Equipment $119.3M $146.8M
YoY Change -18.73% -21.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $78.60M $62.50M
YoY Change 25.76% 62.34%
Total Long-Term Assets $798.5M $780.3M
YoY Change 2.33% -12.21%
TOTAL ASSETS
Total Short-Term Assets $2.005B $2.019B
Total Long-Term Assets $798.5M $780.3M
Total Assets $2.804B $2.800B
YoY Change 0.15% -21.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $378.0M $217.4M
YoY Change 73.87% -46.94%
Accrued Expenses $487.5M $512.1M
YoY Change -4.8% -9.06%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $11.00M $8.900M
YoY Change 23.6%
Total Short-Term Liabilities $1.071B $932.4M
YoY Change 14.91% -21.93%
LONG-TERM LIABILITIES
Long-Term Debt $23.60M $32.10M
YoY Change -26.48% -32.42%
Other Long-Term Liabilities $35.80M $124.1M
YoY Change -71.15% 520.5%
Total Long-Term Liabilities $35.80M $124.1M
YoY Change -71.15% 83.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.071B $932.4M
Total Long-Term Liabilities $35.80M $124.1M
Total Liabilities $1.537B $1.456B
YoY Change 5.53% -14.04%
SHAREHOLDERS EQUITY
Retained Earnings -$272.8M -$173.0M
YoY Change 57.69% -149.93%
Common Stock $1.621B $1.594B
YoY Change 1.74% 2.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.267B $1.344B
YoY Change
Total Liabilities & Shareholders Equity $2.804B $2.800B
YoY Change 0.15% -21.05%

Cashflow Statement

Concept 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$2.800M -$108.7M
YoY Change -97.42% 76.46%
Depreciation, Depletion And Amortization $12.60M $15.30M
YoY Change -17.65% -13.07%
Cash From Operating Activities -$109.1M -$103.4M
YoY Change 5.51% 799.13%
INVESTING ACTIVITIES
Capital Expenditures $10.10M -$20.50M
YoY Change -149.27% 51.85%
Acquisitions
YoY Change
Other Investing Activities -$42.10M $400.0K
YoY Change -10625.0% -500.0%
Cash From Investing Activities -$52.20M -$20.10M
YoY Change 159.7% 47.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.700M -1.900M
YoY Change 42.11% -100.18%
NET CHANGE
Cash From Operating Activities -109.1M -103.4M
Cash From Investing Activities -52.20M -20.10M
Cash From Financing Activities -2.700M -1.900M
Net Change In Cash -164.0M -125.4M
YoY Change 30.78% -112.42%
FREE CASH FLOW
Cash From Operating Activities -$109.1M -$103.4M
Capital Expenditures $10.10M -$20.50M
Free Cash Flow -$119.2M -$82.90M
YoY Change 43.79% -4245.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-58900000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
46000000.0 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
5400000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5500000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3000000.0 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4600000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1400000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-280800000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-362900000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1196000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1319900000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
915200000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
957000000.0 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1322300000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-50500000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8100000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
1200000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7900000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-100000 usd
CY2023Q2 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
-400000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-900000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1271600000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2800000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1400000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
1900000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-300000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q3 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
900000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-100000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1267200000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1602500000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-157900000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3900000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11100000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1100000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-108700000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4400000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7800000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1900000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1343500000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
us-gaap Fiscal Period
FiscalPeriod
The accompanying condensed consolidated financial statements and notes are unaudited. The condensed consolidated financial statements should be read in conjunction with our Annual Report on Form 10-K for the 52 weeks ended January 28, 2023 ("fiscal 2022"), as filed with the Securities and Exchange Commission ("SEC") on March 28, 2023 (the “2022 Annual Report on Form 10-K”). Due to the seasonal nature of our business, our results of operations for the six months ended July 29, 2023 are not indicative of our future results for the 53 weeks ending February 3, 2024 ("fiscal 2023"). Our fiscal year is composed of the 52 or 53 weeks ending on the Saturday closest to the last day of January. Fiscal 2023 consists of 53 weeks ending on February 3, 2024. Fiscal 2022 consisted of 52 weeks ended on January 28, 2023. All six month periods presented herein contain 26 weeks. All references to years, quarters and months relate to fiscal periods rather than calendar periods. Our business, like that of many retailers, is seasonal, with the major portion of the net sales realized during the fourth quarter, which includes the holiday selling season.
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Estimates</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying footnotes. We regularly evaluate the estimates related to our assets and liabilities, contingent assets and liabilities, and the reported amounts of revenues and expenses. In preparing these condensed consolidated financial statements, we have made our best estimates and judgments of certain amounts recognized in the condensed consolidated financial statements, giving due consideration to materiality. Changes in the estimates and assumptions that we have used could have a significant impact on our financial results. Actual results could differ from those estimates.</span></div>
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
304800000 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1139000000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
41300000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
15700000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1196000000 usd
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
33700000 usd
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
304200000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
304700000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
304000000.0 shares
CY2023Q3 us-gaap Revenues
Revenues
1163800000 usd
CY2022Q3 us-gaap Revenues
Revenues
1136000000 usd
us-gaap Revenues
Revenues
2400900000 usd
us-gaap Revenues
Revenues
2514400000 usd
CY2023Q3 us-gaap Deferred Credits And Other Liabilities Current
DeferredCreditsAndOtherLiabilitiesCurrent
286700000 usd
CY2022Q3 us-gaap Deferred Credits And Other Liabilities Current
DeferredCreditsAndOtherLiabilitiesCurrent
323100000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
338200000 usd
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
378300000 usd
gme Increase To Contract Liabilities
IncreaseToContractLiabilities
320100000 usd
gme Increase To Contract Liabilities
IncreaseToContractLiabilities
361300000 usd
gme Decrease To Contract Liabilities
DecreaseToContractLiabilities
371000000.0 usd
gme Decrease To Contract Liabilities
DecreaseToContractLiabilities
414000000.0 usd
gme Contract With Customer Liability Increase Decrease From Other Adjustments
ContractWithCustomerLiabilityIncreaseDecreaseFromOtherAdjustments
-600000 usd
gme Contract With Customer Liability Increase Decrease From Other Adjustments
ContractWithCustomerLiabilityIncreaseDecreaseFromOtherAdjustments
-2500000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
286700000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
323100000 usd
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
33700000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2500000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
CY2023Q3 us-gaap Revenues
Revenues
1163800000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-16600000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
34600000 usd
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
41000000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
39500000 usd
CY2023Q3 us-gaap Debt Current
DebtCurrent
11000000 usd
CY2022Q3 us-gaap Debt Current
DebtCurrent
8900000 usd
CY2023Q1 us-gaap Debt Current
DebtCurrent
10800000 usd
CY2023Q3 gme Letters Of Credit And Bank Guarantees Outstanding Amount
LettersOfCreditAndBankGuaranteesOutstandingAmount
13600000 usd
CY2023Q3 gme Letters Of Credit And Bank Guarantees Outstanding Cash Collateral Amount
LettersOfCreditAndBankGuaranteesOutstandingCashCollateralAmount
12500000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
304800000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
304200000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
304700000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
304000000.0 shares
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q3 us-gaap Revenues
Revenues
1136000000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-107800000 usd
us-gaap Revenues
Revenues
2400900000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-75000000.0 usd
us-gaap Revenues
Revenues
2514400000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-261500000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.067
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1200000 usd
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.011
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-300000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.006
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4700000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.018
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001326380-23-000047-index-headers.html Edgar Link pending
0001326380-23-000047-index.html Edgar Link pending
0001326380-23-000047.txt Edgar Link pending
0001326380-23-000047-xbrl.zip Edgar Link pending
creditagreementwellsgamest.htm Edgar Link pending
ex311-fy23q2.htm Edgar Link pending
ex312-fy23q2.htm Edgar Link pending
ex321-fy23q2.htm Edgar Link pending
ex322-fy23q2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gme-20230729.htm Edgar Link pending
gme-20230729.xsd Edgar Link pending
gme-20230729_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
gme-20230729_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
gme-20230729_lab.xml Edgar Link unprocessable
gme-20230729_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
gme-20230729_cal.xml Edgar Link unprocessable
gme-20230729_pre.xml Edgar Link unprocessable